BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35927414)

  • 1. Long Non-coding RNA UCA1a Promotes Proliferation via PKM2 in Cervical Cancer.
    Yu M; Xue S; Chen X; Wu K; Ju L; Tang J; Xiong A; Chen X; Ying X
    Reprod Sci; 2023 Feb; 30(2):601-614. PubMed ID: 35927414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
    Wang Y; Chen W; Yang C; Wu W; Wu S; Qin X; Li X
    Int J Oncol; 2012 Jul; 41(1):276-84. PubMed ID: 22576688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 5. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M; Zhao X; Yuan X; Jiang J; Li P
    Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non‑coding RNA BCYRN1 promotes glycolysis and tumor progression by regulating the miR‑149/PKM2 axis in non‑small‑cell lung cancer.
    Lang N; Wang C; Zhao J; Shi F; Wu T; Cao H
    Mol Med Rep; 2020 Mar; 21(3):1509-1516. PubMed ID: 32016455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein.
    Lee SA; Ho C; Troxler M; Lin CY; Chung SH
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33800513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
    Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
    Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
    Yang M; Zhai X; Xia B; Wang Y; Lou G
    Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.
    Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X
    Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
    Li R; Li P; Wang J; Liu J
    Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
    Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
    Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
    Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
    J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326/PKM2 axis.
    Wang Y; Yang F; Peng Q; Mei K; He H; Yang Q
    J Gene Med; 2022 Aug; 24(8):e3440. PubMed ID: 35816558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NF‑κB pathway.
    Wang C; Zou H; Yang H; Wang L; Chu H; Jiao J; Wang Y; Chen A
    Mol Med Rep; 2019 Sep; 20(3):2433-2440. PubMed ID: 31322217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
    Wang Q; Ding J; Nan G; Lyu Y; Ni G
    J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.